Among active 13F managers last quarter, 4 opened and 7 added, while 1 reduced; the largest holder to move was Eversept Partners, LP (+2.1%). Over the last 180 days, 2 insiders bought and none sold, a net +$270K in open-market trades.
Funds lean in and no leg opposes.
29 tracked 13F filers disclose a position in GRCE as of the latest SEC 13F filings, a combined $13.1M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Cerity Partners LLC | 849K | $3.9M | ▲+101% Added · +426K sh | Q1 2026 | |
| 2 | Eversept Partners, LP | 773K | $1.8M | ▲+2.1% Added · +16K sh | Q2 2026 | |
| 3 | Bank Of America Corp | 495K | $2.3M | ▲~0% Added · +25 sh | Q1 2026 | |
| 4 | Vanguard Capital Management LLC | 412K | $935K | ▲+2.5% Added · +10K sh | Q2 2026 | |
| 5 | Citadel Advisors LLC | 350K | $794K | ▲+254% Added · +251K sh | Q2 2026 | |
| 6 | Renaissance Technologies LLC | 244K | $1.1M | ▲+88% Added · +114K sh | Q1 2026 | |
| 7 | Jane Street Group, LLC | 167K | $774K | ▲New +167K sh | Q1 2026 | |
| 8 | Birchview Capital, LP | 120K | $272K | ▲+140% Added · +70K sh | Q2 2026 | |
| 9 | Marshall Wace, LLP | 91K | $423K | ▲New +91K sh | Q1 2026 | |
| 10 | XTX Topco Ltd | 63K | $292K | ▲+108% Added · +33K sh | Q1 2026 | |
| 11 | BlackRock, Inc. | 38K | $85K | ▲New +38K sh | Q2 2026 | |
| 12 | UBS Group AG | 26K | $122K | ▲New +26K sh | Q1 2026 | |
| 13 | Rangeley Capital, LLC | 26K | $59K | ▲New +26K sh | Q2 2026 | |
| 14 | Kestra Private Wealth Services, LLC | 23K | $52K | ▲+77% Added · +10K sh | Q2 2026 | |
| 15 | Stratos Investment Management, LLC | 11K | $25K | ▲New +11K sh | Q2 2026 | |
| 16 | Scientech Research LLC | 10K | $23K | ▲New +10K sh | Q2 2026 | |
| 17 | Oppenheimer & Co Inc | 10K | $23K | —Held | Q2 2026 | |
| 18 | Vanguard Fiduciary Trust Co | 9K | $20K | —Held | Q2 2026 | |
| 19 | BNP Paribas Financial Markets | 7K | $33K | ▲12× Added · +7K sh | Q1 2026 | |
| 20 | Morgan Stanley | 5K | $21K | ▼−82% Reduced · −21K sh | Q1 2026 | |
| 21 | National Bank Of Canada | 3K | $13K | —Held | Q1 2026 | |
| 22 | Wells Fargo & Company | 2K | $8K | ▲New +2K sh | Q1 2026 | |
| 23 | Arax Advisory Partners | 1K | $2K | ▲+100% Added · +500 sh | Q2 2026 | |
| 24 | Royal Bank Of Canada | 543 | $3K | —Held | Q1 2026 | |
| 25 | Tower Research Capital LLC (TRC) | 415 | $2K | ▼−79% Reduced · −2K sh | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 4 funds opened a new position in GRCE and 7 added to an existing one, while 1 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Eli Lilly & CoLLY | 12 funds | $2.0B |
| Lam Research CorpLRCX | 12 funds | $738.5M |
| Advanced Micro DevicesAMD | 11 funds | $1.9B |
| Tesla IncTSLA | 11 funds | $1.7B |
| Meta Platforms Inc-Class AMETA | 11 funds | $1.6B |
| Intel CorpINTC | 11 funds | $1.3B |
| Unitedhealth Group IncUNH | 11 funds | $1.2B |
| Sandisk CorpSNDK | 11 funds | $1.1B |
| Kla CorpKLAC | 11 funds | $1.0B |
| Berkshire Hathaway Inc-CL BBRK/B | 11 funds | $985.7M |
| Texas Instruments IncTXN | 11 funds | $864.9M |
| Freeport-McMoran IncFCX | 11 funds | $510.8M |
Ranked by how many of GRCE's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in GRCE.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Sep 9, 2026 | Kohli Prashant | Chief Executive Officer, Director | Buy (P) | 100K | $214K |
| Sep 9, 2026 | Opaleye Management Inc. | 10% Owner | Buy (P) | 6K | $12K |
| Sep 8, 2026 | Opaleye Management Inc. | 10% Owner | Buy (P) | 9K | $20K |
| Aug 14, 2026 | Opaleye Management Inc. | 10% Owner | Buy (P) | 12K | $24K |
| Sep 25, 2023 | Kavuru Vimal | Director, 10% Owner | Buy (P) | 676K | $1.3M |
| Aug 31, 2023 | Olds Donald | Director | Buy (P) | 381 | $781 |
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 13 | 2 | – |
Insiders Form 4 open-market | 2 | 0 | +$270K |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for GRCE
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/GRCE/capital-change-brief"
Use Arkolith's capital_change_brief for GRCE. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + end-of-day price history + the live filing stream, joined for GRCE. Filings are public domain, sourced to SEC EDGAR; price series derived from end-of-day closes.